Dr Reddy's Launches Cancer Drug Abiraterone Acetate In US Market
The drug is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson
Topics
Dr Reddy's Laboratories Limited | cancer drug | Dr Reddy’s cancer drug
BS Reporter |
The drug, which is used in cancer treatment, is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson.
Dr Reddy's Laboratories Limited today announced the launch of Abiraterone Acetate Tablets in the US market, following approval from the US Food and Drug Administration (USFDA).
The drug, which is used in cancer treatment, is a therapeutic equivalent generic version of Zytiga owned by Johnson & Johnson.
Abiraterone Acetate is a significant launch for the company, as the Zytiga brand and generic market had US sales of approximately $454 million for the most recent twelve months ending in March 2020 according to IQVIA Health.
First Published: Fri, June 19 2020. 15:30 IST
PREVIOUS STORY
NEXT STORY
';if(neverShowNotificaitonCookie==''||neverShowNotificaitonCookie=='undefined'||neverShowNotificaitonCookie==null){var lastReminderCookie=getCookie('_ler'+loginParamObj.uId);if((lastReminderCookie=="")||(lastReminderCookie=="undefined")||(lastReminderCookie==null)){$('body').prepend(notificationBox);}else{if(lastReminderCookie
JPMorgan Deploys AI Chatbot To Revolutionize Research And Productivity
JPMorgan has deployed an AI-based research analyst chatbot to enhance productivity among its workforce, with approximate... Read more
Private Equity And Banks: The Complex Web Of Leverage
Private equity has emerged as a significant force in the global financial landscape, driving substantial growth and inve... Read more
Financial Watchdog Highlights Unresolved Vulnerabilities In Shadow Banking Sector
The world’s leading financial stability watchdog has issued a warning about the unresolved vulnerabilities within the ... Read more
JPMorgan And Small Caps Lead Market Rally: A Sign Of Economic Optimism
In a week marked by strong financial performance, JPMorgan Chase & Co. reported a 25% rise in profits, and US small-... Read more
Big Banks Vs. Regional Banks: The Battle For Market Share
The financial industry is a competitive landscape where big banks and regional banks vie for market share. Each type of ... Read more
The Evolution Of Philanthropic Advisory Services In Private Banks
The landscape of philanthropic advisory services provided by private banks has undergone a significant transformation. T... Read more